Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Ladiratuzumab

LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.LadiratuzumAb can be used for the prevention and treatment of breast cancer.

Product Specifications

CAS Number

1629760-28-6

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

1- (4-Fluoro-3-methylphenyl) -2,2-dimethyl-1-propanone
PC1008796-01 250 mg

1- (4-Fluoro-3-methylphenyl) -2,2-dimethyl-1-propanone

Sign In for Pricing
View Details
1- (4-Fluoro-3-methylphenyl) -2,2-dimethyl-1-propanone
PC1008796-02 500 mg

1- (4-Fluoro-3-methylphenyl) -2,2-dimethyl-1-propanone

Sign In for Pricing
View Details
1- (4-Fluoro-3-methylphenyl) -2,2-dimethyl-1-propanone
PC1008796-03 1 g

1- (4-Fluoro-3-methylphenyl) -2,2-dimethyl-1-propanone

Sign In for Pricing
View Details
Human recombinant VEGFR1/Flt-1 protein
PROTP17948-7-500ug 500 µg

Human recombinant VEGFR1/Flt-1 protein

Sign In for Pricing
View Details
Rnase11 Rat siRNA Oligo Duplex (Locus ID 497651)
SR505251 1 Kit

Rnase11 Rat siRNA Oligo Duplex (Locus ID 497651)

Sign In for Pricing
View Details
NDUFA8 (C-6) : m-IgG2a BP-HRP Bundle
sc-546562 1 Kit

NDUFA8 (C-6) : m-IgG2a BP-HRP Bundle

Sign In for Pricing
View Details